Physician

Nathan Francis Pezda, M.D.

According to 2025 Medicare claims, Nathan Pezda, M.D. (NPI: 1669602033) practices ophthalmology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Ottawa, MI. This provider's primary affiliated billing organization is RETINA SPECIALISTS OF MICHIGAN PC (NPI: 1801048699; TIN: 26-3453700) and primary practice location at 49444-1881.

Pezda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 439 traditional Medicare patients, billed 12,698 HCPCS/CPT codes, and received $1,303,920 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 365 prescription claims across 145 beneficiaries totaling $16,451 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 43 records totaling $20,458. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	597	5,547	$934,854
2016	680	6,261	$1,046,157
2017	761	7,281	$1,236,225
2018	608	6,251	$1,150,814
2019	619	6,257	$1,185,340
2020	436	5,107	$1,183,771
2021	413	5,204	$1,226,527
2022	453	5,116	$1,111,836
2023	415	8,793	$1,139,135
2024	439	12,698	$1,303,920

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	90	255	$16,419
2016	104	337	$23,201
2017	117	406	$32,444
2018	129	393	$38,405
2019	123	402	$41,118
2020	83	301	$27,314
2021	92	227	$23,126
2022	126	282	$19,665
2023	118	258	$14,890
2024	145	365	$16,451

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	109	1,024	$653
67028	Injection of drug into eye	208	889	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	210	251	$82
92134	Imaging of retina	408	1,205	$27
92250	Photography of the retina	128	153	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	159	4,873	$6,000
Bromfenac Sodium	Bromfenac Sodium	18	565	$2,511
Gentamicin Sulfate	Gentamicin Sulfate	71	1,547	$709
Timolol Maleate	Timolol Maleate	36	3,169	$526
Brimonidine Tartrate	Brimonidine Tartrate	14	1,045	$313

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$3,553	Alimera Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$16,905	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$28,421	US Retina LLC

Explore More Providers

FAQ

What Medicare data is available for Nathan Francis Pezda, M.D.?

Tedicare shows public-source Medicare data for Nathan Francis Pezda, M.D. (NPI 1669602033), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathan Francis Pezda, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nathan Francis Pezda, M.D.?

Nathan Francis Pezda, M.D. is linked to RETINA SPECIALISTS OF MICHIGAN PC (billing NPI 1801048699) in the available physician profile data.

Does Nathan Francis Pezda, M.D. have Open Payments data?

Nathan Francis Pezda, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.